DHL has doubled the number of its global depots from eight to 16, aiming to strengthen its position as a leading global clinical trials logistics (CTL) provider.
New depots are located in India, China, Panama, Canada, the US, Chile, Argentina and Lebanon, and means the operator can offer CTL services across 64 countries.

DHL said the expansion enabled it to service additional key research sites around the world and integrate emerging markets into global supply chains.